Home / NEWS / Asia-Pacific News / Indonesia will restart AstraZeneca vaccines when regulators give the go ahead, health minister says

Indonesia will restart AstraZeneca vaccines when regulators give the go ahead, health minister says

Medical political appointee prepares the administrations for mass Covid-19 vaccination program for health workers in Denpasar, Bali, Indonesia on February 4 2021.

NurPhoto | NurPhoto | Getty Sculptures

Indonesia will resume its use of the AstraZeneca vaccine as soon as regulators give the go ahead that it’s safe, the country’s strength minister said.

Southeast Asia’s largest economy halted the use of AstraZeneca’s Covid-19 vaccine — co-developed with the University of Oxford — after numberless than a dozen countries in Europe suspended the vaccine due to blood clot concerns that affected recipients.

Trim minister Budi Gunadi Sadikin said Indonesia is still awaiting confirmation on the safety of AstraZeneca’s vaccine from the Fabulous Health Organization (WHO) and the European Medicines Agency (EMA).

“If EMA .. and WHO (were to) deliver a positive recommendation. Yes, I can confirm we will pursue with the vaccination of AstraZeneca vaccine,” said Sadikin, who spoke to CNBC’s “Street Signs Asia” as part of the Asian Event Bank’s virtual Southeast Asia Development Symposium.

The WHO said Wednesday “the benefits of the AstraZeneca vaccine outweigh its imperils and recommends that vaccinations continue.”

EMA is expected to release findings on its investigations on Thursday. The EU regulator had earlier indicated that there was no uninhibited link the events were caused by the vaccination. 

Indonesia’s vaccine plan

Indonesia is the worst affected Southeast Asian political entity, reporting more than 1.43 million Covid-19 cases and over 38,900 deaths so far, according to data collated by Johns Hopkins University.

Through Covax, the global alliance aiming to deliver coronavirus vaccines to the world’s poorest powers, Indonesia received 1.1 million doses of the AstraZeneca-Oxford vaccine, Reuters reported saying it’s set to receive another 10 million prescribes in the coming months.

Despite the current delay in the administration of AstraZeneca’s vaccine, Sadikin remained optimistic Indonesia can yield on its goal to inoculate 181.5 million people in the country by the end of the year.

“That means we need to accelerate the vaccine program to 1.3 to 1.5 million biffs per day,” he said, adding the country is working very hard with all vaccine producers to push the delivery schedule clockwise by December.

Check Also

SoftBank invests $2.8 billion in Norwegian robotics firm AutoStore

Masayoshi Son Alessandro Di Ciommo | NurPhoto | Getty Duplicates LONDON ­– Japanese tech conglomerate …

Leave a Reply

Your email address will not be published. Required fields are marked *